Latest
FTW: NYC at New York Fintech Week 2026 Signals a Structural Shift in Financial InfrastructureFTW: NYC at New York Fintech Week 2026 Signals a Structural Shift in Financial Infrastructure|Inside FirstMark’s Data Driven NYC #121: Where AI Infrastructure Meets Fintech RealityInside FirstMark’s Data Driven NYC #121: Where AI Infrastructure Meets Fintech Reality|Building Software Factories That Scale Without Breaking Trust: A DirectorPlus Gathering by Peter Bell and Gather.devBuilding Software Factories That Scale Without Breaking Trust: A DirectorPlus Gathering by Peter Bell and Gather.dev|GovConWire Signals a FedRAMP Breakthrough as Knox Systems Pushes Sub-90-Day Authorization for SaaSGovConWire Signals a FedRAMP Breakthrough as Knox Systems Pushes Sub-90-Day Authorization for SaaS|Lucra Raises $20M Series B Led by ARK to Power Real-Money Loyalty and Engagement PlatformsLucra Raises $20M Series B Led by ARK to Power Real-Money Loyalty and Engagement Platforms|Leisure Hydration Closes Oversubscribed Series A to Expand Functional Hydration Brand NationwideLeisure Hydration Closes Oversubscribed Series A to Expand Functional Hydration Brand Nationwide|QXO Acquires TopBuild in $17B Deal to Expand Building Products Distribution and Installation PlatformQXO Acquires TopBuild in $17B Deal to Expand Building Products Distribution and Installation Platform|Sierra Acquires Fragment to Expand Multilingual AI Customer Service CapabilitiesSierra Acquires Fragment to Expand Multilingual AI Customer Service Capabilities|Tesla Plans Up to $2B Stock-Based Acquisition of AI Hardware Company, Filing ShowsTesla Plans Up to $2B Stock-Based Acquisition of AI Hardware Company, Filing Shows|Ferrosa Therapeutics Raises $3.5M Seed to Advance Bispecific Antibody for Anemia of InflammationFerrosa Therapeutics Raises $3.5M Seed to Advance Bispecific Antibody for Anemia of Inflammation|FTW: NYC at New York Fintech Week 2026 Signals a Structural Shift in Financial InfrastructureFTW: NYC at New York Fintech Week 2026 Signals a Structural Shift in Financial Infrastructure|Inside FirstMark’s Data Driven NYC #121: Where AI Infrastructure Meets Fintech RealityInside FirstMark’s Data Driven NYC #121: Where AI Infrastructure Meets Fintech Reality|Building Software Factories That Scale Without Breaking Trust: A DirectorPlus Gathering by Peter Bell and Gather.devBuilding Software Factories That Scale Without Breaking Trust: A DirectorPlus Gathering by Peter Bell and Gather.dev|GovConWire Signals a FedRAMP Breakthrough as Knox Systems Pushes Sub-90-Day Authorization for SaaSGovConWire Signals a FedRAMP Breakthrough as Knox Systems Pushes Sub-90-Day Authorization for SaaS|Lucra Raises $20M Series B Led by ARK to Power Real-Money Loyalty and Engagement PlatformsLucra Raises $20M Series B Led by ARK to Power Real-Money Loyalty and Engagement Platforms|Leisure Hydration Closes Oversubscribed Series A to Expand Functional Hydration Brand NationwideLeisure Hydration Closes Oversubscribed Series A to Expand Functional Hydration Brand Nationwide|QXO Acquires TopBuild in $17B Deal to Expand Building Products Distribution and Installation PlatformQXO Acquires TopBuild in $17B Deal to Expand Building Products Distribution and Installation Platform|Sierra Acquires Fragment to Expand Multilingual AI Customer Service CapabilitiesSierra Acquires Fragment to Expand Multilingual AI Customer Service Capabilities|Tesla Plans Up to $2B Stock-Based Acquisition of AI Hardware Company, Filing ShowsTesla Plans Up to $2B Stock-Based Acquisition of AI Hardware Company, Filing Shows|Ferrosa Therapeutics Raises $3.5M Seed to Advance Bispecific Antibody for Anemia of InflammationFerrosa Therapeutics Raises $3.5M Seed to Advance Bispecific Antibody for Anemia of Inflammation
Back to articles

Minish Technology Raises $22M From VIG Partners at $110M Valuation to Expand Biomimetic Dentistry Platform

Funding Details

Amount

$22M

Minish Technology just pulled $22M into the room and didn’t bother to make a lot of noise about it. That’s usually how you know something serious is happening. Quiet capital, sharp thesis, and a product that doesn’t need a TED Talk to prove it works. Los Angeles may be the headline, but the roots run through Seoul, where precision isn’t branding, it’s muscle memory.

Jung Ho Kang is steering this with the kind of focus you don’t fake. When your company is built around keeping what people already have instead of replacing it, you’re not just selling dentistry, you’re selling restraint. Biomimetic tech sounds like a mouthful until you realize it’s really about one thing: respecting the original design. Enamel, structure, longevity. Not a cover-up, not a shortcut. Preservation over performance theater.

VIG Partners stepping in with a $22M check for a 20% stake puts the valuation around $110M, and more importantly, puts institutional conviction behind a category that’s been hiding in plain sight. Dental isn’t sexy until it is. Then everyone suddenly remembers they have teeth. The jump from roughly $8M raised to north of $30M total tells you this wasn’t luck. It was sequencing. Build the clinical credibility first, then scale the machine.

Over 160,000 clinical applications didn’t come from a marketing funnel. That’s repetition, refinement, and a system that dentists can actually use without feeling like they’re beta testing someone else’s ambition. Minish isn’t just selling a product, they’re building a provider network, training, and a workflow that turns precision into something repeatable. That’s how you move from niche to standard.

The Los Angeles presence isn’t a vanity play either. It’s distribution, education, and proximity to a market that values aesthetics but demands results. You don’t bring a 0.1mm precision story into the U.S. unless you’re ready to be questioned, tested, and scaled. That tension is where real companies get built.

There’s a lesson here that founders love to ignore. You don’t always win by doing more. Sometimes you win by doing less damage. Minish Technology leaned into that idea and turned it into a platform. Capital followed.

Now the interesting part isn’t the $22M. It’s what happens when minimally invasive stops being a niche preference and starts becoming the expectation. That’s when the market shifts under everyone’s feet, and the companies who practiced discipline early start looking a lot like the ones who saw it coming all along